NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品名: ABILIFY MAINTENA KIT (ARIPIPRAZOLE) ANDA: NDA #202971 NDC:59148-019-71 制造公司: OTSUKA PHARM CO LTD 活性物质: ARIPIPRAZOLE 剂量: 400MG/VIAL 使用方式: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 营销状态: Prescription 批准日期: 10/08/2014批准类型: Approval ...
产品名称:CARBOPROST TROMETHAMINE上市时间:02/13/2023NDA/ANDA/BLA:216882持证商:CAPLINNDC:65145-132-10,71839-137-10说明书:批准信:
产品名称:HYDRALAZINE HYDROCHLORIDE上市时间:02/13/2023NDA/ANDA/BLA:215147持证商:EUGIA PHARMANDC:55150-400-25说明书:批准信:
产品名称:BEMUSTINE HYDROCHLORIDE上市时间:02/13/2023NDA/ANDA/BLA:214739持证商:EUGIA PHARMA SPECLTSNDC:说明书:批准信:
产品名称:BOSENTAN上市时间:02/13/2023NDA/ANDA/BLA:213981持证商:ZYDUS PHARMS USA INCNDC:说明书:批准信:
产品名称:LEVONORGESTREL AND ETHINYL ESTRADIOL上市时间:02/13/2023NDA/ANDA/BLA:212298持证商:HETERO LABSNDC:31722-944-32说明书:批准信:
产品名称:GEFITINIB上市时间:02/13/2023NDA/ANDA/BLA:211591持证商:QILU PHARM HAINANNDC:50742-366-30,67184-0531-1,67184-0531-2,67184-0531-3说明书:批准信:
产品名称:CANAGLIFLOZIN上市时间:02/13/2023NDA/ANDA/BLA:210541持证商:ZYDUS PHARMS USA INCNDC:说明书:批准信:
产品名称:IBRUTINIB上市时间:02/10/2023NDA/ANDA/BLA:215464持证商:SANDOZ INCNDC:说明书:批准信:
产品名称:SILDENAFIL CITRATE上市时间:02/10/2023NDA/ANDA/BLA:212260持证商:NOVITIUM PHARMANDC:70954-168-10说明书:批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/212260Orig1s000ltr.pdf
产品名称:ZEMDRI 上市时间:02/10/2023NDA/ANDA/BLA:210303持证商:CIPLA USANDC:80735-820-96,71045-010-02,69097-820-96说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210303Orig1s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/210303Orig1s000Ltr.pdf